￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
FDA approves olaparib/olaparib/abiraterone for companion diagnosis of BRCA+mCRPC

2026-02-01 22:25:32

Check Details
Application and effect of olaparib/olaparib in the treatment of triple-negative breast cancer

2026-02-01 22:25:32

Check Details
Lynparib/olaparib: anticancer efficacy and potential risks

2026-02-01 22:25:32

Check Details
Olaparib vs. Lynparib: Different names for the same drug

2026-02-01 22:25:32

Check Details
Is Lynparib/Olaparib tablets an over-the-counter drug?

2026-02-01 22:25:32

Check Details
Mechanism of action and uses of Lynparib/Olaparib

2026-02-01 22:25:32

Check Details
What are the effects of midostaurin?

2026-02-01 22:25:32

Check Details
How much does midostaurin targeted drug cost?

2026-02-01 22:25:32

Check Details
What therapeutic effects does Midostaurin have?

2026-02-01 22:25:32

Check Details
What are the common adverse reactions of midostaurin?

2026-02-01 22:25:32

Check Details
Midostaurin indications, usage and dosage

2026-02-01 22:25:32

Check Details
Midostaurin: the world’s first targeted drug for acute myeloid leukemia

2026-02-01 22:25:32

Check Details
Category
相关知识